MAINTAINING DNA REPLICATION FORK STABILITY: ROLE OF THE FANCONI ANEMIA PATHWAY
MAINTAINING DNA REPLICATION FORK STABILITY: ROLE OF THE FANCONI ANEMIA PATHWAY
批准号:
7960146
负责人:
Niall George Howlett
金额:
$19.96万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-04 至 2010-04-30
关键词:
AphidicolinBehavioral ResearchCellsChromosome BreakageChromosome Fragile SitesCisplatinClinicalComputer Retrieval of Information on Scientific Projects DatabaseDNADNA Crosslinking AgentDNA IntegrationDNA Polymerase InhibitorDNA biosynthesisDNA replication forkDNA-Directed DNA PolymeraseDiseaseFANCD2 proteinFHIT geneFanconi&aposs AnemiaFrequenciesFundingGenomicsGrantHuman PapillomavirusInstitutionLeadMaintenanceMalignant NeoplasmsMapsMitomycinsMono-SMutationNeoplastic Cell TransformationPancytopeniaPathway interactionsPatientsPhysiologicalPlayPredispositionPreventionResearchResearch PersonnelResourcesRoleSiteSourceUbiquitinationUnited States National Institutes of Healthin vivoinsightresponsetumor
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
Fanconi贫血(FA)是一种罕见的隐性遗传性疾病,以先天性异常、骨髓衰竭和明显的癌症易感性为特征。FA患者细胞对DNA交联剂如丝裂霉素C和顺铂高度敏感。然而,FA途径的内源性功能仍不清楚。我们最近已经证明,FA通路在细胞对DNA复制中断的反应中是功能所必需的。DNA聚合酶抑制剂APH处理FANCD2蛋白后,FANCD2蛋白通过单一泛素化被强烈激活。此外,在APH处理后,FA途径的取消会导致更多的染色体断裂,包括常见的染色体脆性部位FRA3B和FRA16D的断裂。我们假设FA通路在维持DNA复制分叉稳定性方面发挥着不可或缺的作用,这是防止肿瘤转化的关键功能。为了进一步了解这一功能,本文提出了两个目标。首先,我们将描述FANCD2蛋白与主要DNA聚合酶处理因子--增殖细胞核抗原之间的相互作用。具体地说,我们将检查最近发现的FANCD2增殖细胞核抗原相互作用基序突变的功能后果。其次,我们将确定APH诱导的FA细胞染色体断裂增加是否导致外源DNA整合增加。最后,我们将尝试建立FA途径在维持DNA复制分叉稳定性中的作用的临床推论:我们将通过绘制FA患者肿瘤中HPV整合的基因组位置,来确定FA细胞常见的染色体脆性位点断裂增加是否与这些位点上人类乳头瘤病毒(HPV)DNA整合频率增加有关。我们建议的研究将导致关于FA通路在体内的生理作用的新发现,并为FA患者增加癌症易感性提供洞察力。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Fanconi anemia (FA) is a rare recessive disorder characterized by congenital anomalies, bone marrow failure, and pronounced cancer susceptibility. FA patient cells are hypersensitive to DNA crosslinking agents such as mitomycin C and cisplatin. The endogenous function of the FA pathway, however, remains unknown. We have recently demonstrated that the FA pathway is functionally required for the cellular response to disruption of DNA replication. The FA pathway is strongly activated via the mono-ubiquitination of the FANCD2 protein following treatment with the DNA polymerase inhibitor aphidicolin (APH). Furthermore, abrogation of the FA pathway leads to increased chromosome breakage, including breakage at the common chromosomal fragile sites FRA3B and FRA16D, following treatment with APH. We hypothesize that the FA pathway plays an integral role in the maintenance of DNA replication fork stability, a function critical for the prevention of neoplastic transformation. Two aims are proposed to gain further insight into this function. First, we will characterize the interaction between the FANCD2 protein and the major DNA polymerase processivity factor PCNA. Specifically, we will examine the functional consequences of mutation of a recently identified FANCD2 PCNA-interaction motif. Second, we will determine if the increased APH-induced chromosome breakage in FA cells leads to increased integration of foreign DNA. Finally, we will attempt to establish a clinical corollary for a role of the FA pathway in the in the maintenance of DNA replication fork stability: We will determine if the increased common chromosomal fragile site breakage of FA cells is associated with an increased frequency of human papillomavirus (HPV) DNA integration at these loci, by mapping the genomic sites of HPV integration in FA patient tumors. Our proposed studies will lead to new findings regarding the in vivo physiological role of the FA pathway, and provide insight into the increased cancer susceptibility of FA patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
-
批准号:10735366
-
项目类别:
-
资助金额:$8.4万
-
财政年份:2023
-
负责人:Niall George Howlett
-
依托单位:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
-
批准号:10078631
-
项目类别:
-
资助金额:$38.44万
-
财政年份:2020
-
负责人:Niall George Howlett
-
依托单位:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
-
批准号:10320390
-
项目类别:
-
资助金额:$30.57万
-
财政年份:2020
-
负责人:Niall George Howlett
-
依托单位:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
-
批准号:10535080
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2020
-
负责人:Niall George Howlett
-
依托单位:
MARC U*STAR Training Program at the University of Rhode Island
-
批准号:10626735
-
项目类别:
-
资助金额:$18.83万
-
财政年份:2019
-
负责人:Niall George Howlett
-
依托单位:
Administrative Supplement for the MARC U*STAR Training Program at the University of Rhode Island: Graduate Student Inclusive Mentoring Training
-
批准号:10592680
-
项目类别:
-
资助金额:$6.31万
-
财政年份:2019
-
负责人:Niall George Howlett
-
依托单位:
MARC U*STAR Training Program at the University of Rhode Island
-
批准号:10401820
-
项目类别:
-
资助金额:$29.34万
-
财政年份:2019
-
负责人:Niall George Howlett
-
依托单位:
Regulation of the Mono-Ubiquitination of the Fanconi Anemia D2 Protein
-
批准号:8435367
-
项目类别:
-
资助金额:$34.27万
-
财政年份:2011
-
负责人:Niall George Howlett
-
依托单位:
Regulation of the Mono-Ubiquitination of the Fanconi Anemia D2 Protein
-
批准号:8040615
-
项目类别:
-
资助金额:$26.06万
-
财政年份:2011
-
负责人:Niall George Howlett
-
依托单位:
Regulation of the Mono-Ubiquitination of the Fanconi Anemia D2 Protein
-
批准号:8527272
-
项目类别:
-
资助金额:$3.09万
-
财政年份:2011
-
负责人:Niall George Howlett
-
依托单位:
Regulation of the Mono-Ubiquitination of the Fanconi Anemia D2 Protein
-
批准号:9012411
-
项目类别:
-
资助金额:$6.5万
-
财政年份:2011
-
负责人:Niall George Howlett
-
依托单位:
Regulation of the Mono-Ubiquitination of the Fanconi Anemia D2 Protein
-
批准号:8248173
-
项目类别:
-
资助金额:$26.12万
-
财政年份:2011
-
负责人:Niall George Howlett
-
依托单位:
Regulation of the Mono-Ubiquitination of the Fanconi Anemia D2 Protein
-
批准号:8627198
-
项目类别:
-
资助金额:$35.29万
-
财政年份:2011
-
负责人:Niall George Howlett
-
依托单位:
MAINTAINING DNA REPLICATION FORK STABILITY: ROLE OF THE FANCONI ANEMIA PATHWAY
-
批准号:8167617
-
项目类别:
-
资助金额:$6.0万
-
财政年份:2010
-
负责人:Niall George Howlett
-
依托单位:
Searching for a New Fanconi Anemia-BRCA Pathway Gene on Chromosome 11p
-
批准号:7640217
-
项目类别:
-
资助金额:$18.63万
-
财政年份:2009
-
负责人:Niall George Howlett
-
依托单位:
Searching for a New Fanconi Anemia-BRCA Pathway Gene on Chromosome 11p
-
批准号:7807185
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2009
-
负责人:Niall George Howlett
-
依托单位:
MAINTAINING DNA REPLICATION FORK STABILITY: ROLE OF THE FANCONI ANEMIA PATHWAY
-
批准号:7725161
-
项目类别:
-
资助金额:$18.66万
-
财政年份:2008
-
负责人:Niall George Howlett
-
依托单位:
MAINTAINING DNA REPLICATION FORK STABILITY: ROLE OF THE FANCONI ANEMIA PATHWAY
-
批准号:7609983
-
项目类别:
-
资助金额:$11.92万
-
财政年份:2007
-
负责人:Niall George Howlett
-
依托单位:
Rhode Island IDeA Network for Excellence in Biomedical Research
-
批准号:10192740
-
项目类别:
-
资助金额:$298.67万
-
财政年份:2001
-
负责人:Niall George Howlett
-
依托单位:
Rhode Island IDeA Network for Excellence in Biomedical Research
-
批准号:10619577
-
项目类别:
-
资助金额:$294.65万
-
财政年份:2001
-
负责人:Niall George Howlett
-
依托单位:
海外基金